Xu et al.
COMMUNICATION
sidered as a potential platform to produce value-added
chemicals. The impact of bipyridine ligand’s structure
on the activity of Cp*Ir complex was systematically
researched. The hydrogenation rate extremely increased
when the bipyridine ligand was modified by both dime-
thylamino (NMe2) and ortho-hydroxyl groups (o-OH)
(Scheme 2). The o-OH group assisted the H2 heterolytic
dissociation,[31-43] and the electron-donating ability of
both NMe2 and o-OH increased the hydrogenation ac-
tivity of the Cp*Ir-L complex. In this work, we investi-
gated the reductive amination of LA by Cp*Ir-L com-
plex under H2 atmosphere.
(m, 1H), 1.21-1.19 (m, 3H); 13C NMR (100 MHz,
CDCl3) δ: 174.2, 137.6, 129.0, 125.7, 124.0, 55.6, 31.4,
26.8, 20.2.
5-Methyl-1-(p-tolyl)pyrrolidin-2-one (2b, 179.8 mg,
95%):[25] 1H NMR (400 MHz, CDCl3, TMS) δ: 7.24-
7.17 (m, 4H), 4.28-4.19 (m, 1H), 2.66-2.47 (m, 2H),
2.40-2.30 (m, 4H), 1.78-1.68 (m, 1H), 1.19-1.17
(m, 3H); 13C NMR (100 MHz, CDCl3) δ: 174.2, 135.6,
135.0, 129.6, 124.2, 55.8, 31.3, 26.8, 21.0, 20.2.
1-(4-Methoxyphenyl)-5-methylpyrrolidin-2-one (2c,
191.0 mg, 93%):[25] 1H NMR (400 MHz, CDCl3, TMS)
δ: 7.25-7.21 (m, 2H), 6.93-6.89 (m, 2H), 4.21-4.13
(m, 1H), 3.78 (s, 1H), 2.63-2.46 (m, 2H), 2.38-2.28
(m, 1H), 1.76-1.67 (m, 1H), 1.15 (d, J=6.24 Hz, 3H);
13C NMR (100 MHz, CDCl3) δ: 174.1, 157.5, 130.3,
125.9, 114.2, 55.9, 55.3, 31.0, 26.7, 20.1.
Scheme 2 Structure of Cp*Ir-L complex of this work. OTf is
trifluoromethanesulfonate
2+
Me2N
1-(4-Fluorophenyl)-5-methylpyrrolidin-2-one (2d,
173.5 mg, 90%):[25] 1H NMR (400 MHz, CDCl3, TMS)
δ: 7.35-7.29 (m, 2H), 7.10-7.04 (m, 2H), 4.27-4.19
(m, 1H), 2.66-2.48 (m, 2H), 2.40-2.32 (m, 1H),
1.79-1.70 (m, 1H), 1.18 (d, J=6.24 Hz, 3H); 13C
NMR (100 MHz, CDCl3) δ: 174.3, 160.4 (d, J=244
Hz), 133.5 (d, J=3 Hz), 126.0 (d, J=8 Hz), 115.8 (d,
J=22 Hz), 55.9, 31.2, 26.7, 20.1.
Cp*
N
IrIII
2 OTf-
N
H2O
OH
Cp*Ir-L
1-(4-Chlorophenyl)-5-methylpyrrolidin-2-one (2e,
187.0 mg, 89%):[25] 1H NMR (400 MHz, CDCl3, TMS)
δ: 7.36-7.31 (m, 4H), 4.30-4.22 (m, 1H), 2.66-2.46
(m, 2H), 2.39-2.30 (m, 1H), 1.78-1.69 (m, 1H), 1.19
(d, J=6.24 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ:
174.1, 136.2, 130.6, 128.9, 124.8, 55.3, 31.2, 26.5, 19.9.
Experimental
General methods
NMR spectra were run in CDCl3 on a 400 MHz in-
strument and recorded at the following frequencies:
proton (1H, 400 MHz), carbon (13C, 100 MHz). H
1
1-(4-Bromophenyl)-5-methylpyrrolidin-2-one
(2f,
NMR chemical shifts were reported using tetrame-
thylsilane (TMS) as the internal standard. 13C NMR
spectra were reported using CDCl3 as the internal
standard.
223.6 mg, 88%):[25] 1H NMR (400 MHz, CDCl3, TMS)
δ: 7.51-7.47 (m, 2H), 7.31-7.28 (m, 2H), 4.32—4.24
(m, 1H), 2.67-2.48 (m, 2H), 2.41-2.32 (m, 1H),
1.79-1.71 (m, 1H), 1.20 (d, J=6.24 Hz, 3H); 13C
NMR (100 MHz, CDCl3) δ: 174.2, 136.8, 132.1, 125.2,
118.7, 55.4, 31.3, 26.6, 20.0.
Preparation of Cp*Ir-L
The Cp*Ir-L was prepared according to the litera-
ture.[30] 1H NMR (400 MHz, CD3OD) δ: 1.65 (s, 15H),
3.29 (s, 6H), 7.02—7.05 (m, 1H), 7.21—7.23 (m, 1H),
7.58 (d, J=2.88 Hz, 1H), 8.09—8.13 (m, 2H), 8.53 (d,
J=6.96 Hz, 1H); 13C NMR (100 MHz, CD3OD) δ: 8.1,
38.6, 88.8, 105.8, 109.9, 113.3, 114.8, 120.4 (q, J=317
Hz), 143.6, 149.6, 154.5, 155.9, 156.1, 163.9.
Ethyl 4-(2-methyl-5-oxopyrrolidin-1-yl)benzoate (2g,
160.7 mg, 65%):[25] 1H NMR (400 MHz, CDCl3, TMS)
δ: 8.08-8.04 (m, 2H), 7.57-7.54 (m, 2H), 4.45-4.34
(m, 3H), 2.73-2.51 (m, 2H), 2.43-2.35 (m, 1H),
1.88-1.74 (m, 1H), 1.39 (t, J=7.12 Hz, 3H), 1.26 (d,
J=6.24 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ: 174.4,
166.2, 141.9, 130.5, 126.8, 122.0, 61.0, 55.1, 31.5, 26.5,
19.9, 14.4.
Synthesis of pyrrolidinone 2
To a solution of LA (162.4 mg, 1.4 mmol) in water
(2.0 mL) at room temperature was added Cp*Ir catalyst
(0.43 mg, 0.0005 mmol) and aniline (1.0 mmol). The
high pressure reactor (20 mL) was purged with H2 (20
bar) four times, and was heated to 80 ℃ for 10 h. The
aqueous solution was extracted by CH2Cl2 (5.0 mL)
three times. After removing the combined CH2Cl2, the
crude residue was purified on a silica gel column to af-
ford the product 2.
5-Methyl-1-phenylpyrrolidin-2-one (2a, 166.3 mg,
95%).[25] 1H NMR (400 MHz, CDCl3, TMS) δ: 7.41-
7.36 (m, 4H), 7.22-7.18 (m, 1H), 4.33-4.27 (m, 1H),
2.68-2.49 (m, 1H), 2.41-2.32 (m, 1H), 1.79-1.70
1-(4-Benzylphenyl)-5-methylpyrrolidin-2-one
(2i,
217.5 mg, 82%):[25] 1H NMR (400 MHz, D2O) δ: 7.50-
7.45 (m, 5H), 4.26-4.16 (m, 2H), 3.36-3.28 (m, 1H),
2.40-2.21 (m, 2H), 2.07-1.98 (m, 1H), 1.84-1.75
(m, 1H), 1.36 (t, J=6.64 Hz, 3H); 13C NMR (100 MHz,
D2O) δ: 181.4, 131.2, 129.6, 129.5, 129.3, 54.4, 48.4,
33.6, 29.0, 15.5.
1-Butyl-5-methylpyrrolidin-2-one (2j, 97.8 mg,
63%):[27] 1H NMR (400 MHz, D2O) δ: 3.10-2.97 (m,
2H), 2.75-2.36 (m, 3H), 2.02-1.66 (m, 4H), 1.42-
1.34 (m, 5H), 0.96 (t, J=6.64 Hz, 3H); 13C NMR (100
MHz, D2O) δ: 179.4, 55.1, 44.5, 35.7, 29.4, 28.4, 20.2,
17.3, 13.7.
2
© 2017 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Chin. J. Chem. 2017, XX, 1—5